Theobromine, caffeine, and theophylline metabolites in human plasma and urine after consumption of soluble cocoa products with different methylxanthine contents

Food Research International

Volumn 63, Issue , 2014, Pages 446-455

  Martínez López, Sara ^a   Sarriá, Beatriz ^a   Gómez Juaristi, Miren ^a   Goya, Luis ^a   Mateos, Raquel ^a   Bravo Clemente, Laura ^a  

^a INSTITUTE OF FOOD SCIENCE   (Spain)

Author keywords

Bioavailability; Cocoa; Human; Liquid chromatography; Methylxanthines

Indexed keywords

BIOCHEMISTRY; BIOMOLECULES; BODY FLUIDS; CAFFEINE; LIQUID CHROMATOGRAPHY; METABOLITES;

BIOACTIVE COMPONENTS; BIOAVAILABILITY; BIOLOGICAL FLUIDS; HUMAN; MAXIMUM CONCENTRATIONS; METHYLXANTHINES; NATURALLY OCCURRING; URINARY METABOLITES; HUMAN PLASMAS;

COCOA;

THEOBROMA CACAO;

EID: 84907164159     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2014.03.009     Document Type: Article

References (40)

1. Apgar J.L., Tarka S.M. Methylxanthines. Chocolate and cocoa: Health and nutrition 1999, 153-173. Blackwell Sciences, Oxford, UK. I. Knight (Ed.).
2. Arnaud M.J. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handbook of Experimental Pharmacology 2011, 200:33-91.
3. Atia N.N., York P., Clark B.J. Development and validation of a rapid and efficient method for simultaneous determination of methylxanthines and their metabolites in urine using monolithic HPLC columns. Journal of Separation Science 2009, 32:931-938.
4. Bravo L., Saura-Calixto F. Characterization of the dietary fiber and the in vitro indigestible fraction of grape pomace. American Journal of Enology and Viticulture 1998, 49:135-141.
5. Cooper K.A., Donovan J.L., Waterhouse A.L., Williamson G. Cocoa and health: A decade of research. British Journal of Nutrition 2008, 99(1):1-11.
6. Corti R., Flammer A.J., Hollenberg N.K., Lüscher T.F. Cocoa and cardiovascular health. Circulation 2009, 119:1433-1441.
7. Daly J.W. Caffeine and analogues: Biomedical impact. Cellular and Molecular Life Sciences 2007, 64:2153-2169.
8. De Sena A.R., Aparecida de Assis S., Branco A. Analysis of theobromine and related compounds by reversed phase High-Performance Liquid Chromatography with ultraviolet detection: An update (1992-2011). Food Technology and Biotechnology 2011, 49:413-423.
9. Emara S. Simultaneous determination of caffeine, theophylline and theobromine in human plasma by on-line solid-phase extraction coupled to reversed-phase chromatography. Biomedical Chromatography 2004, 18:479-485.
10. Food and Agriculture Organization of the United Nations, FAO Medium-term prospects for agricultural commodities. Projections to the year 2010 2003, FAO, ROME.
11. Georga K.A., Samanidou V.F., Papadoyannis I.N. Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. Journal of Chromatography B 2001, 759:209-218.
12. Jalil A.M.M., Ismail A., Pei Pei C., Hamid M., Kamaruddin S.H. Effects of cocoa extract on glucometabolism, oxidative stress, and antioxidant enzymes in obese-diabetic (Ob-db) rats. Journal of Agricultural and Food Chemistry 2008, 56:7877-7884.
13. Kuwazawa T., Seno H., Lee X.-P., Akiro I., Watanabe-Suzuki K., Sato K., et al. Extraction of methylxanthines from human body fluids by solid-phase microextraction. Analytica Chimica Acta 1999, 387:53-60.
14. Lang R., Dieminger N., Beusch A., Lee Y.M., Dunkel A., Suess B., et al. Bioappareance and pharmacokinetics of bioactives upon coffee consumption. Analytical and Bioanalytical Chemistry 2013, 405(26):8487-8503.
15. Llorach R., Urpi-Sarda M., Jauregui O., Monagas M., Andres-Lacueva C. An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. Journal of Proteome Research 2009, 8:5060-5068.
16. Martin M.A., Ramos S., Mateos R., Granado A.B., Izquierdo-Pulido M., Bravo L., et al. Protection of human HepG2 cells against oxidative stress by cocoa phenolic extract. Journal of Agricultural and Food Chemistry 2008, 56:7765-7772.
17. Mitchell E.S., Slettenaar M., Meer N., Transler C., Jans L., Quadt F., et al. Differential contributions of theobromine and caffeine on mood, psychomotor performance and blood pressure. Physiology & Behaviour 2011, 104:816-822.
18. Mumford G.K., Benowitz N.L., Evans S.M., Kaminski B.J., Preston K.L., Sannerud C.A., et al. Absorption rate of methylxanthines following capsules, cola and chocolate. European Journal of Clinical Pharmacology 1996, 51:319-325.
19. Neufingerl N., Zebregs Y., Schuring E., Trautwein E. Effect of cocoa and theobromine consumption on serum HDL-cholesterol concentrations: A randomized controlled trial. The American Journal of Clinical Nutrition 2013, 97(6):1201-1209.
20. Okuro M., Fujiki N., Kotorii N., Ishimaru Y., Sokoloff P., Nishino N. Effects of paraxanthine and caffeine on sleep, locomotor activity, and body temperature in orexin/ataxin-3 transgenic narcoleptic mice. Sleep 2010, 33:930-942.
21. Porkka-Heiskanen T., Zitting K.M., Wigren H.K. Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiologica 2013, 208(4):311-328.
22. Ptolemy A.S., Tzioumis T., Thomke A., Rifai S., Kellogg M. Quantification of theobromine and caffeine in saliva, plasma and urine via liquid chromatography-tandem mass spectrometry: A single analytical protocol applicable to cocoa intervention studies. Journal of Chromatography B 2010, 878:409-416.
23. Rodopoulos N., Hojvall L., Norman A. Elimination of theobromine metabolites in healthy adults. Scandinavian Journal of Clinical and Laboratory Investigation 1996, 56:373-383.
24. Rodopoulos N., Norman A. Determination of caffeine and its metabolites in urine by high-performance liquid chromatography and capillary electrophoresis. Scandinavian Journal of Clinical & Laboratory Investigation 1994, 54:305-315.
25. Rodopoulos N., Norman A. Assessment of dimethylxanthine formation form caffeine in healthy adults: Comparison between plasma and saliva concentrations and urinary excretion of metabolites. Scandinavian Journal of Clinical and Laboratory Investigation 1996, 56:259-268.
26. Rodopoulos N., Norman A. Elimination of theophylline metabolites in healthy adults. Scandinavian Journal of Clinical and Laboratory Investigation 1997, 57:233-240.
27. Rodopoulos N., Wisen O., Norman A. Caffeine metabolism in patients with chronic liver disease. Scandinavian Journal of Clinical and Laboratory Investigation 1995, 55:229-242.
28. Rodriguez-Ramiro I., Martín M.A., Ramos S., Bravo L., Goya L. Comparative effects of dietary flavanols on antioxidant defences and their response to oxidant-induced stress on Caco2 cells. European Journal of Nutrition 2010, 50:313-322.
29. Rubio L., Valls R.M., Macia A., Pedret A., Giralt M., Romero M.P., et al. Impact of olive oil phenolic concentration on human plasmatic phenolic metabolites. Food Chemistry 2012, 135:2922-2929.
30. Sarria B., Martinez-Lopez S., Fernandez-Espinosa A., Gomez-Juriasti M., Goya L., Mateos R., et al. Effects of regularly consuming dietary fibre rich soluble cocoa products on bowel habits in healthy subjects: A free-living, two-stage, randomized, crossover, single-blind intervention. Nutrition and Metabolism 2012, 9:1-10.
31. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson L., et al. Caffeine therapy for apnea of prematurity. The New England Journal of Medicine 2006, 354:2112-2121.
32. Schneider H., Ma L., Glatt H. Extractionless method for the determination of urinary caffeine metabolites using high-performance liquid chromatography coupled with tandem mass spectrometry. Journal of Chromatography B 2003, 789:227-237.
33. Schreiber-Deturmeny E., Bruguerolle B. Simultaneous high-performance liquid chromatographic determination of caffeine and theophylline for routine drug monitoring in human plasma. Journal of Chromatography B 1996, 677:305-312.
34. Smit H.J., Gaffan E.A., Rogers P.J. Methylxanthines are the psycho-pharmacologically active constituents of chocolate. Psychopharmacology 2004, 176:412-419.
35. Stavric B. Methylxanthines: Toxicity to humans. Theophylline. Food and Chemical Toxicology 1988, 26:541-565.
36. Taubert D., Roesen R., Lehmann C., Jung N., Schöming E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: A randomized controlled trial. The Journal of the American Medical Association 2007, 298:49-60.
37. Thevis M., Opfermann G., Krug O., Schanzwer W. Electrospray ionization mass spectrometric characterization and quantization of xanthine derivatives using isotopically labelled analogues: An application for equine doping control analysis. Rapid Communications in Mass Spectrometry 2004, 18:1553-1560.
38. Usmani O.S., Belvisi M.G., Patel H.J., Crispino N., Birrel M.A., Korbonits M., et al. Theobromine inhibits sensory nerve activation and cough. The FASEB Journal 2005, 19(2):231-233.
39. Zambonin C.G., Aresta A., Palmisano F. Determination of methylxanthines in urine by liquid chromatography with diode array UV detection. Journal of Pharmaceutical and Biomedical Analysis 2004, 36:621-624.
40. Zydron M., Baranowski J., Baranowska I. Separation, pre-concentration, and HPLC analysis of methylxanthines in urine samples. Journal of Separation Science 2004, 27:1166-1172.